Unprecedented advances have been made in the treatment of gastrointestinal cancer over the past 25 years. At this year’s World Congress, nearly 3000 clinicians, researchers and practitioners discussed the latest findings and innovative therapies. The focus was on immunotherapy as well as new biomarkers for prevention and prognosis as well as possibilities for gene analysis.
This content is machine-translated. Please contact us if you need professional translation services.
Publikation
- InFo ONKOLOGIE & HÄMATOLOGIE
